ClinicalTrials.gg
CompletedNCT07753915Updated Aug 10, 2026

A Study on the Development and Application of a Cardiac Rehabilitation Nursing Intervention Protocol for Patients With First-Episode Acute Myocardial Infarction Following PCI, Based on a Socio-Ecological Theory Model

An interventional study of A Cardiac Rehabilitation Nursing Intervention Program Based on the Social-Ecological Theory Model in Acute Myocardial Infarction (AMI) and Percutaneous Coronary Intervention (PCI), sponsored by Jinzhou Medical University. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-10.

Sponsored by Jinzhou Medical University · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Mar 2026, registered Aug 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 196 studies in Myocardial Infarction with a site in China — 64 open to participants now, 73 under way, 8 of them phase 3. Myocardial Infarction · China.

Enrollment
93rd of 107
66 · median 366
Started
2026
with 19 others
No phase
44 of 196
14 open now
Registered
192nd of 196
by date

Among the 196 studies in Myocardial Infarction with a site in China, this one is the 93rd largest by enrollment of the 107 interventional ones that give a count, is one of 20 that started in 2026, is one of 44 with no phase, and was the 192nd registered.

Myocardial Infarction

2,273 studies on the registry are indexed under Myocardial Infarction; 373 are open to participants now.

Browse Myocardial Infarction studies →

Open to participants now

64 of the 196 studies in Myocardial Infarction with a site in China are open now. Recruiting first, the newest first:

59 more — sign in →

All 64 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 256 Myocardial Infarction studies recruiting now, 173 (68%) set no upper age limit and 25 (10%) stop at 75 or younger; 17 take children under 18; 27 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 196 studies in Myocardial Infarction with a site in China, or all of them as a file.
02

Study summary

The purpose of this [Study Type: Clinical Trial] is to investigate whether a cardiac rehabilitation nursing intervention based on the socio-ecological model can improve rehabilitation-related outcomes in patients. The study population consists of [adult patients with acute myocardial infarction who have undergone percutaneous coronary intervention (PCI)]. The primary research questions addressed in this study are:

  1. Can a social-ecological model-based cardiac rehabilitation intervention improve adherence to cardiac rehabilitation among patients with myocardial infarction following PCI?]
  2. Can a social-ecological model-based cardiac rehabilitation intervention improve cardiac function and quality of life among patients with myocardial infarction following PCI?] The researchers will compare the [intervention group and the control group] to observe whether there are [group differences in cardiac rehabilitation adherence, cardiac function, and quality of life levels].

Intervention group: Receives routine cardiology care combined with a social-ecological model-based cardiac rehabilitation intervention (1. In-hospital guidance; 2. Multidimensional, continuous rehabilitation support at home and in the community; 3. Regular follow-up assessments, etc.); Control Group: Received routine care from the cardiology department and standard discharge cardiac rehabilitation education; All participants completed questionnaire surveys and had cardiac function-related indicators collected at baseline, 3 months into the intervention, and 6 months into the intervention.

03

Conditions studied

  • Acute Myocardial Infarction (AMI)
  • Percutaneous Coronary Intervention (PCI)
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with a first-time diagnosis of acute myocardial infarction who underwent PCI for the first time;
  • Age ≥ 18 years;
  • Alert and able to communicate effectively; ④ Willing to participate and sign an form.

Exclusion criteria

Exclusion Criteria:

  • Presence of absolute to exercise (e.g., unstable angina, severe heart failure, malignant arrhythmias, etc.);
  • Concurrent severe comorbidities (e.g., end-stage renal disease, malignant tumors, severe cognitive impairment);
  • Participation in other rehabilitation clinical trials.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
66 participants (actual)

Study arms

  • No intervention
    Control Group
  • Experimental
    Intervention Group

    Other: A Cardiac Rehabilitation Nursing Intervention Program Based on the Social-Ecological Theory Model

Interventions

  • OtherA Cardiac Rehabilitation Nursing Intervention Program Based on the Social-Ecological Theory Model

    Building on routine cardiac nursing care, implement a cardiac rehabilitation nursing intervention based on the socio-ecological model, with an intervention period of 1 month. Interventions were carried out at the individual, interpersonal, organizational, community, and policy levels: at the individual level, guidance was provided on exercise, diet, medication, and emotional management; at the organizational level, a multidisciplinary rehabilitation team was established; at the interpersonal level, family members were mobilized to participate in collaborative care; at the community level, a system of continuous follow-up management was established, with monthly online and in-person rehabilitation guidance and assessments; and at the policy level, policy interpretation and guidance were provided to different population groups.

06

What researchers measure

Primary outcomes

  1. Left Ventricular Ejection Fraction

    Time frame: From enrollment through the end of the three-month follow-up

07

Study locations

1 site
  • The First Affiliated Hospital of Jinzhou Medical University
    Jinzhou, Liaoning 121001, China
08

References and documents

Individual participant data

Plan to share: No — To protect patient privacy, all raw data will be uploaded to the ResMan Clinical Trial Management Platform (https://www.myresman.com/) six months after the study is completed.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2026 to primary completion in Jun 2026, 3 months.

Of 322 non-industry interventional studies with no phase under Myocardial Infarction, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 58. This study's 3 months is below that.

Counting every sponsor, half of 355 studies reached it within 34 months; a quarter within 15 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 3, 2026
First posted
Aug 10, 2026
StartActual
Mar 14, 2026
Primary completionActual
Jun 20, 2026
CompletionActual
Jun 20, 2026
Last update
Aug 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07753915
Lead sponsor
Jinzhou Medical University
Responsible party
Zhang Yuyu (Nurse, Jinzhou Medical University) — Principal investigator
First posted
Aug 10, 2026
Start date
Mar 14, 2026
Primary completion
Jun 20, 2026
Completion
Jun 20, 2026
Last update
Aug 10, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion